Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on My Healthcare Reporter.
Press releases published on July 31, 2025
PepCare Reimagines Digital Dental Referrals with Platform Refresh
EIN Presswire
·
July 31, 2025
PepCare’s redesigned UI and website streamline dental referrals and care coordination, helping practices reduce admin burden and improve efficiency. KENOSHA, WI, UNITED STATES, July 31, 2025 /EINPresswire.com/ -- PepCare (www.pepcare.com), a digital …
Oncology Companion Diagnostics Market Driven by Targeted Therapies & Biomarker Advances | DataM Intelligence
EIN Presswire
·
July 31, 2025
Oncology companion diagnostics market grows with rising demand for personalized cancer treatments, biomarker discovery, and regulatory approvals TEXAS, TX, UNITED STATES, July 31, 2025 /EINPresswire.com/ -- Oncology companion diagnostics (CDx) are …
Ourian Plastic Surgery Announces New Content on Surgery Options for Women, Including Insurance Options
EIN Presswire
·
July 31, 2025
Ourian Plastic Surgery is proud to announce new content. Many clients can secure insurance funding for surgeries that they may not think are 'covered.' BEVERLY HILLS, CA, UNITED STATES, July 30, 2025 /EINPresswire.com/ -- Ourian Plastic Surgery, a best- …
Lung Cancer Diagnostics Market to Hit $8.44 Billion by 2033, Driven by Precision Tools & Liquid Biopsy Advances | DataM
EIN Presswire
·
July 31, 2025
Lung cancer diagnostics market grows steadily, fueled by increasing cancer prevalence, biomarker research, AI integration, and non-invasive screening demand. TEXAS, TX, UNITED STATES, July 31, 2025 /EINPresswire.com/ -- The lung cancer diagnostics …
BioPREVAIL Launches Call for Proposals in World Design Challenge for Sustainable Diagnostic Containment Laboratories
EIN Presswire
·
July 31, 2025
Global Affair's Canada, World Organisation for Animal Health, and Global Health Security Fund Unite to Foster Innovation for One Health Security Initiative GENEVA, SWITZERLAND, July 31, 2025 /EINPresswire.com/ -- BioPREVAIL, a One Health Security …
Medicinal Genomics Earns AOAC Certification for Aspergillus Assays
EIN Presswire
·
July 31, 2025
New AOAC-validated assay with MaGiC™ Lysis delivers results up to 66% faster, increases lab throughput, and streamlines DNA extraction. BEVERLY, MA, UNITED STATES, July 31, 2025 /EINPresswire.com/ -- Medicinal Genomics Corp. (MGC), a pioneering leader …
Naples Laser & Skin Aesthetics Now Offers Medical-Grade Peels for Advanced Skin Renewal
EIN Presswire
·
July 31, 2025
Naples Laser …
Avadel Pharmaceuticals to Provide a Corporate Update and Report Second Quarter 2025 Financial Results on August 7
GlobeNewswire
·
July 31, 2025
DUBLIN, Ireland, July 31, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it will host a conference call and live webcast at 8:30 a.m …
Lisata Therapeutics to Report Second Quarter 2025 Financial Results and Provide a Business Update on Thursday, August 7, 2025
GlobeNewswire
·
July 31, 2025
BASKING RIDGE, N.J., July 31, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other …
CytomX Therapeutics to Report Second Quarter 2025 Financial Results on August 7, 2025
GlobeNewswire
·
July 31, 2025
SOUTH SAN FRANCISCO, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologic therapeutics, today announced that it will report second quarter financial results on …
LifeMD Names COO and Promotes Two Executives
GlobeNewswire
·
July 31, 2025
NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual healthcare services, today announced the appointment of Shayna Webb Dray as its Chief Operating Officer. Ms. Webb Dray, an accomplished operations and …
Akebia Therapeutics to Report Second Quarter 2025 Financial Results and Discuss Recent Business Highlights
GlobeNewswire
·
July 31, 2025
CAMBRIDGE, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA) today announced plans to release its financial results for the second quarter ended June 30, 2025, on Thursday, August 7, 2025, prior to the open of financial …
Dr. Michelle LeRoux Williams Earns Washington Business Journal’s Medical Device Innovator Award
GlobeNewswire
·
July 31, 2025
GAITHERSBURG, Md., July 31, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today announced that Dr. Michelle LeRoux Williams, Chief Scientific Officer, has been awarded the …
Lexicon Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement
GlobeNewswire
·
July 31, 2025
THE WOODLANDS, Texas, July 31, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Nasdaq’s listing qualifications staff has determined that the closing bid price of the Company’s common stock has been at $1.00 per …
Nautilus Biotechnology Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
July 31, 2025
SEATTLE, July 31, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the second quarter ended June 30, 2025. “In Q2, …
Incannex Confirms Strong Cash Position; No Plans or Requirement to Fully Utilise ATM in Near Term
GlobeNewswire
·
July 31, 2025
MELBOURNE, Australia, July 31, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) (“Incannex” or the “Company”) announced, in response to recent questions it received from a number of its stockholders, that it does not presently intend to use …
VedTechBio Unveils Next-Gen Drug Discovery AI; Partners with AlphaMeld in Multi-Therapy Collaboration
GlobeNewswire
·
July 31, 2025
BENGALURU, India, July 31, 2025 (GLOBE NEWSWIRE) -- VedTechBio Research Pvt. Ltd., a pioneer in AI-driven drug discovery, today announced major enhancements to its RxAgentAI™ platform, cutting drug discovery timelines in half, alongside a strategic …
Inka Health Selected by OneMedNet to Lead AI-Driven Oncology Project Using Real-World Data for External Control Arms
GlobeNewswire
·
July 31, 2025
VANCOUVER, British Columbia, July 31, 2025 (GLOBE NEWSWIRE) -- Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H, WKN: A3EKSZ) ("Onco" or the "Company”) is pleased to announce that its wholly owned subsidiary, Inka Health Corp. ("Inka …
Nuvectis Pharma Provides Final Clinical Data Update from the NXP800 Phase 1b Study in Ovarian Cancer and Reports Completion of the NXP900 Phase 1a Dose Escalation Study
GlobeNewswire
·
July 31, 2025
Available data from 13 patients with recurrent, platinum resistant, ARID1a-mutated ovarian cancer treated with 75 mg/day in the NXP800 Phase 1b study includes 2 partial responses and 3 stable diseases; thrombocytopenia successfully managed with …
Crescent Biopharma Reports Second Quarter 2025 Financial Results and Recent Business Highlights
GlobeNewswire
·
July 31, 2025
Completed Merger with GlycoMimetics and Previously Announced $200 Million Private Financing Supporting Pipeline of Next Generation Therapeutics for Solid Tumors Recent Leadership Appointments Bring Deep Experience in Oncology Drug Development, Clinical …